Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaitong Buzu Re Granules in Hepatitis A (Phase II)
CTR20191010Phase 2Active
- Sponsor
- Xinjiang Uygur Autonomous Region Institute of Drug Research
- Start
- May 2019
- Countries
- 1
01
Overview
A Phase 2 trial of Kaitong Buzu Re granules in hepatitis A (HAV), sponsored by Xinjiang Uygur Autonomous Region Institute of Drug Research. Started May 2019; status: active.
02
Drugs
Kaitong Buzu Re granules
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on CTR20191010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191010.